Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia
Clinical trial NCT03512405 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03512405
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-02
- Primary completion
- 2025-11-11
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.